Harvard Bioscience (HBIO) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.50 -2.4%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $20.6 million versus the consensus estimate of $19 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
- Wendy's U.S. president to resign, company to create COO role
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
